Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; TSX: $TGOD.TO, TSXV: $EMH.V, TSXV: $N.V, CSE: $IAN.C, CSE: $BE.C
July 19th Potcast sponsored by Lexaria Bioscience Corp. (CSE: $LXX.C) (OTC: $LXRP) and its drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC - July 19, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its "potcast' site, www.potcasts.ca release today's edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX:TGOD, TSXV:EMH, TSXV:N, CSE:IAN, CSE:BE
Today's podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast; looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today's potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on the OTC as LXRP. Lexaria has developed a new disruptive drug delivery platform: DehydraTECH The Company's patented technology changes the way Active Pharmaceutical Ingredients ("APIs") enter the body orally:
1) Masks unwanted tastes - eliminates the need for sugar-filled edibles.
2) Reduces time of onset - effects are felt within 15-20 min vs. 60-120 min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company's DehydraTECH™ technology is patent-protected for multiple APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble vitamins.
Learn more about Lexaria at www.lexariabioscience.com
Today we will be looking at announcements from The Green Organic Dutchman Holdings Ltd. trading on the TSX as TGOD, Emerald Health Therapeutics, Inc. trading on the TSX-Venture as EMH, Namaste Technologies Inc. trading on the TSX-Venture as N, iAnthus Capital Holdings, Inc. trading on the CSE as IAN and the OTCQB as ITHUF and Beleave Inc. trading on the CSE as BE.
The Green Organic Dutchman Holdings Ltd. announced its intention to complete a spinoff transaction by way of plan of arrangement, pursuant to which the Company will distribute a dividend consisting of a warrant in a new corporation ("TGOD Acquisitions") to shareholders. The new corporation will be engaged in the acquisition and development of worldwide opportunities.
TGOD has met with emerging cannabis companies from around the globe and acquired a deep understanding, including proprietary knowledge, of all facets of the cannabis industry. These companies are not considered core assets in TGOD's business plan, and accordingly, they have not been pursued to date. However, the Company now wishes to monetize this unique situation for the benefit of TGOD shareholders. After consultation with multiple financial institutions, TGOD Acquisitions plans to execute a series of staged financings and acquisitions leading to a late 2018 target IPO date.7
Emerald Health Therapeutics, Inc. have signed a definitive agreement to acquire the remaining shares of Northern Vine Canada Inc. (Northern Vine), owned by Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF), for $2 million in cash and $4 million in shares of Emerald stock. This transaction increases Emerald's ownership of Northern Vine from 65% to 100%. Northern Vine is a Licensed Dealer (LD) under the provisions of the Canadian Controlled Drugs and Substances Act.
"Product innovation is a primary pillar of Emerald's global business strategy. The acquisition of Northern Vine allows us to leverage its dealer license and research and development facility to advance our research plans to develop cannabis formulations supporting new products for both recreational purposes and to treat a broad spectrum of human conditions and diseases," said Chris Wagner, CEO of Emerald. "The dealer license would also enable Emerald to cost effectively source non-dried-flower cannabis products from suppliers in other countries."
Namaste Technologies Inc. announced that the company has submitted applications to the Apple and Google Play stores in order to launch its latest mobile application, Uppy Cannabis Journal. Uppy Cannabis Journal is the first artificial intelligence ("AI") driven medical cannabis app, which is designed to collect direct feedback on cannabis strains and over time provide strain and cannabis hardware recommendations. Namaste has implemented its AI technology through the Company's wholly owned subsidiary Findify AB ("Findify" or "Findify.io") and has fed over 2 million pieces of unique data to the platform which forms the base on which the algorithm will evolve and adapt itself to better understand the effects of cannabis strains in relation to treatment of many symptoms.
Through Uppy Cannabis Journal, Namaste's customers and medical cannabis patients will have the access to journal their experiences using various strains of cannabis to treat their symptoms. The data collected over time will allow the algorithm to characterize the way different strains of cannabis benefit different people suffering from different symptoms. The goal of the Uppy Cannabis Journal is to develop a shopping experience whereby patients are provided with the best possible strain recommendations personalized for their needs, based on factual data collected through Namaste's network of e-commerce sites, combined with user-feedback and AI technology.
iAnthus Capital Holdings, Inc., which owns, operates and partners with licensed cannabis operations throughout the United States, announced that Mayflower Medicinals, Inc. ("Mayflower"), a Massachusetts non-profit Registered Marijuana Dispensary ("RMD") license holder affiliated with the Company, is opening its flagship medical cannabis dispensary in Boston.
Located in the neighborhood of Allston, the dispensary will offer patients a full spectrum of medical cannabis products in the form of flower, tinctures, concentrates, oils and vaporizers. Mayflower is the second license holder to open a dispensary within the city of Boston. This inaugural Mayflower location is the 34th dispensary to open within the commonwealth of Massachusetts, which has a population of approximately 6.7 million people.
Beleave Inc. announced the acquisition of 100% of the outstanding shares of Seven Oaks Inc. in an all share deal valued at $3,000,000.
"Seven Oaks has a proven track record of working collaboratively to secure wholesale and distribution agreements with retailers across Canada," said Beleave CEO, Andrew Wnek. "Beleave breaking into the recreational market with solid agreements and impactful branding will be a monumental development for us. Seven Oaks' upcoming distribution will not only improve access to our products for many Canadians, it is also continuing our commitment to driving profitability and value for our shareholders."
Seven Oaks' branding appeals to consumers, both conceptually and in the quality it invokes, attracting them to become repeat customers. This acquisition bridges the gap between sourcing cannabis products from an established producer and retailing by leveraging Seven Oak's marketing platform to provide consistent, recognizable quality across Canada.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
To sponsor this podcast or be a guest
Do you trade or invest in Marijuana / Hemp Stocks? Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing